{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T23:47:15Z","timestamp":1773359235676,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,12,19]],"date-time":"2016-12-19T00:00:00Z","timestamp":1482105600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81270966"],"award-info":[{"award-number":["81270966"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81500679"],"award-info":[{"award-number":["81500679"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Natural Science Foundation of Guangdong Province, China","award":["S2012010009494"],"award-info":[{"award-number":["S2012010009494"]}]},{"name":"the Natural Science Foundation of Guangdong Province, China","award":["2014A030310036"],"award-info":[{"award-number":["2014A030310036"]}]},{"name":"the Natural Science Foundation of Guangdong Province, China","award":["2014A030310472"],"award-info":[{"award-number":["2014A030310472"]}]},{"name":"the Natural Science Foundation of Southern Medical University, Guangdong Province, China","award":["PY2013N050"],"award-info":[{"award-number":["PY2013N050"]}]},{"name":"Science and technology plan of Guangdong province","award":["2016A020215097"],"award-info":[{"award-number":["2016A020215097"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s12020-016-1201-5","type":"journal-article","created":{"date-parts":[[2016,12,19]],"date-time":"2016-12-19T00:37:21Z","timestamp":1482107841000},"page":"732-740","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["ACE inhibitors and the risk of fractures: a meta-analysis of observational studies"],"prefix":"10.1007","volume":"55","author":[{"given":"Yan-Zhen","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen-Zi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ze-Feng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Yang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Xin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Miu Yee","family":"Waye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi-Tao","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,12,19]]},"reference":[{"issue":"3","key":"1201_CR1","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.ecl.2015.05.002","volume":"44","author":"BC Lupsa","year":"2015","unstructured":"B.C. Lupsa, K. Insogna, Bone health and osteoporosis. Endocrinol. Metab. Clin. North. Am. 44(3), 517\u2013530 (2015). doi: 10.1016\/j.ecl.2015.05.002","journal-title":"Endocrinol. Metab. Clin. North. Am."},{"key":"1201_CR2","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.2147\/cia.s54613","volume":"10","author":"X Lin","year":"2015","unstructured":"X. Lin, D. Xiong, Y.Q. Peng, Z.F. Sheng, X.Y. Wu, X.P. Wu, F. Wu, L.Q. Yuan, E.Y. Liao, Epidemiology and management of osteoporosis in the People\u2019s Republic of China: current perspectives. Clin. Interv. Aging. 10, 1017\u20131033 (2015). doi: 10.2147\/cia.s54613","journal-title":"Clin. Interv. Aging."},{"issue":"11","key":"1201_CR3","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1359\/jbmr.1997.12.11.1761","volume":"12","author":"AC Looker","year":"1997","unstructured":"A.C. Looker, E.S. Orwoll, C.J. Johnston, R.L. Lindsay, H.W. Wahner, W.L. Dunn, M.S. Calvo, T.B. Harris, S.P. Heyse, Prevalence of low femoral bone density in older U.S. adults from NHANES III. J. Bone. Miner. Res. 12(11), 1761\u20131768 (1997). doi: 10.1359\/jbmr.1997.12.11.1761","journal-title":"J. Bone. Miner. Res."},{"issue":"12","key":"1201_CR4","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1007\/s00198-008-0634-y","volume":"19","author":"JA Cauley","year":"2008","unstructured":"J.A. Cauley, N.S. Wampler, J.M. Barnhart, L. Wu, M. Allison, Z. Chen, S. Hendrix, J. Robbins, R.D. Jackson, Incidence of fractures compared to cardiovascular disease and breast cancer: the women\u2019s health initiative observational study. Osteoporos. Int. 19(12), 1717\u20131723 (2008). doi: 10.1007\/s00198-008-0634-y","journal-title":"Osteoporos. Int."},{"issue":"5 Suppl 51","key":"1201_CR5","first-page":"S125","volume":"26","author":"GG Teng","year":"2008","unstructured":"G.G. Teng, J.R. Curtis, K.G. Saag, Mortality and osteoporotic fractures: is the link causal, and is it modifiable? Clin. Exp. Rheumatol. 26(5 Suppl 51), S125\u2013137 (2008)","journal-title":"Clin. Exp. Rheumatol."},{"issue":"12","key":"1201_CR6","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1007\/s00198-006-0172-4","volume":"17","author":"O Johnell","year":"2006","unstructured":"O. Johnell, J.A. Kanis, An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos. Int. 17(12), 1726\u20131733 (2006). doi: 10.1007\/s00198-006-0172-4","journal-title":"Osteoporos. Int."},{"issue":"1","key":"1201_CR7","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.amjhyper.2004.08.016","volume":"18","author":"JL Perez-Castrillon","year":"2005","unstructured":"J.L. Perez-Castrillon, J.C. Martin-Escudero, M.P. Alvarez, S.R. Cortes, Z.S. Iglesias, A.M. Garcia, Hypertension as a risk factor for hip fracture. Am. J. Hypertens. 18(1), 146\u2013147 (2005). doi: 10.1016\/j.amjhyper.2004.08.016","journal-title":"Am. J. Hypertens."},{"issue":"7","key":"1201_CR8","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/jhh.2008.156","volume":"23","author":"J Woo","year":"2009","unstructured":"J. Woo, T. Kwok, J. Leung, N. Tang, Dietary intake, blood pressure and osteoporosis. J. Hum. Hypertens. 23(7), 451\u2013455 (2009). doi: 10.1038\/jhh.2008.156","journal-title":"J. Hum. Hypertens."},{"issue":"7 Pt 1","key":"1201_CR9","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0895-7061(01)01303-6","volume":"14","author":"K Tsuda","year":"2001","unstructured":"K. Tsuda, I. Nishio, Y. Masuyama, Bone mineral density in women with essential hypertension. Am. J. Hypertens. 14(7 Pt 1), 704\u2013707 (2001)","journal-title":"Am. J. Hypertens."},{"issue":"3","key":"1201_CR10","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1365-2265.2005.02226.x","volume":"62","author":"L Mosekilde","year":"2005","unstructured":"L. Mosekilde, Vitamin D and the elderly. Clin. Endocrinol. 62(3), 265\u2013281 (2005). doi: 10.1111\/j.1365-2265.2005.02226.x","journal-title":"Clin. Endocrinol."},{"key":"1201_CR11","doi-asserted-by":"publisher","unstructured":"K. Aung, T. Htay, Thiazide diuretics and the risk of hip fracture. Cochrane Database Syst. Rev. (10), CD005185 (2011). doi: 10.1002\/14651858.CD005185.pub2 .","DOI":"10.1002\/14651858.CD005185.pub2"},{"issue":"4","key":"1201_CR12","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/j.1365-2796.2006.01695.x","volume":"260","author":"M Wiens","year":"2006","unstructured":"M. Wiens, M. Etminan, S.S. Gill, B. Takkouche, Effects of antihypertensive drug treatments on fracture outcomes: a meta-analysis of observational studies. J. Intern. Med. 260(4), 350\u2013362 (2006). doi: 10.1111\/j.1365-2796.2006.01695.x","journal-title":"J. Intern. Med."},{"issue":"6","key":"1201_CR13","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1152\/japplphysiol.00182.2010a","volume":"109","author":"LG Navar","year":"2010","unstructured":"L.G. Navar, Counterpoint: activation of the intrarenal renin-angiotensin system is the dominant contributor to systemic hypertension. J. Appl. Physiol. 109(6), 1998\u20132000 (2010). doi: 10.1152\/japplphysiol.00182.2010a . (1985)discussion 2015","journal-title":"J. Appl. Physiol."},{"issue":"8","key":"1201_CR14","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1007\/s00198-011-1831-7","volume":"23","author":"T Kwok","year":"2012","unstructured":"T. Kwok, J. Leung, Y.F. Zhang, D. Bauer, K.E. Ensrud, E. Barrett-Connor, P.C. Leung, Does the use of ACE inhibitors or angiotensin receptor blockers affect bone loss in older men?. Osteoporos. Int. 23(8), 2159\u20132167 (2012). doi: 10.1007\/s00198-011-1831-7","journal-title":"Osteoporos. Int."},{"key":"1201_CR15","doi-asserted-by":"crossref","first-page":"f360","DOI":"10.1136\/bmj.f360","volume":"346","author":"H Makani","year":"2013","unstructured":"H. Makani, S. Bangalore, K.A. Desouza, A. Shah, F.H. Messerli, Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials. BMJ. 346, f360 (2013)","journal-title":"BMJ."},{"issue":"2","key":"1201_CR16","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1359\/jbmr.081006","volume":"24","author":"Y Asaba","year":"2009","unstructured":"Y. Asaba, M. Ito, T. Fumoto, K. Watanabe, R. Fukuhara, S. Takeshita, Y. Nimura, J. Ishida, A. Fukamizu, K. Ikeda, Activation of renin-angiotensin system induces osteoporosis independently of hypertension. J. Bone. Miner. Res. 24(2), 241\u2013250 (2009). doi: 10.1359\/jbmr.081006","journal-title":"J. Bone. Miner. Res."},{"issue":"4","key":"1201_CR17","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1210\/jcem.75.4.1400892","volume":"75","author":"FD Grant","year":"1992","unstructured":"F.D. Grant, S.J. Mandel, E.M. Brown, G.H. Williams, E.W. Seely, Interrelationships between the renin-angiotensin-aldosterone and calcium homeostatic systems. J. Clin. Endocrinol. Metab. 75(4), 988\u2013992 (1992). doi: 10.1210\/jcem.75.4.1400892","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"1201_CR18","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1097\/01.hjh.0000203845.26690.cb","volume":"24","author":"L Rejnmark","year":"2006","unstructured":"L. Rejnmark, P. Vestergaard, L. Mosekilde, Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study. J. Hypertens. 24(3), 581\u2013589 (2006). doi: 10.1097\/01.hjh.0000203845.26690.cb","journal-title":"J. Hypertens."},{"issue":"4","key":"1201_CR19","doi-asserted-by":"publisher","first-page":"e0122691","DOI":"10.1371\/journal.pone.0122691","volume":"10","author":"S Yamamoto","year":"2015","unstructured":"S. Yamamoto, R. Kido, Y. Onishi, S. Fukuma, T. Akizawa, M. Fukagawa, J.J. Kazama, I. Narita, S. Fukuhara, Use of renin-angiotensin system inhibitors is associated with reduction of fracture risk in hemodialysis patients. PLoS. One. 10(4), e0122691 (2015). doi: 10.1371\/journal.pone.0122691","journal-title":"PLoS. One."},{"issue":"4","key":"1201_CR20","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.bone.2005.09.011","volume":"38","author":"H Lynn","year":"2006","unstructured":"H. Lynn, T. Kwok, S.Y. Wong, J. Woo, P.C. Leung, Angiotensin converting enzyme inhibitor use is associated with higher bone mineral density in elderly Chinese. Bone 38(4), 584\u2013588 (2006). doi: 10.1016\/j.bone.2005.09.011","journal-title":"Bone"},{"issue":"22","key":"1201_CR21","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1001\/2013.jamainternmed.469","volume":"172","author":"DA Butt","year":"2012","unstructured":"D.A. Butt, M. Mamdani, P.C. Austin, K. Tu, T. Gomes, R.H. Glazier, The risk of hip fracture after initiating antihypertensive drugs in the elderly. Arch. Intern. Med. 172(22), 1739\u20131744 (2012). doi: 10.1001\/2013.jamainternmed.469","journal-title":"Arch. Intern. Med."},{"issue":"6","key":"1201_CR22","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1007\/s00774-012-0363-3","volume":"30","author":"YF Zhang","year":"2012","unstructured":"Y.F. Zhang, L. Qin, P.C. Leung, T.C. Kwok, The effect of angiotensin-converting enzyme inhibitor use on bone loss in elderly Chinese. J. Bone. Miner. Metab. 30(6), 666\u2013673 (2012). doi: 10.1007\/s00774-012-0363-3","journal-title":"J. Bone. Miner. Metab."},{"key":"1201_CR23","unstructured":"G.A. Wells, B. Shea, D. O\u2019Connell, J. Peterson, V. Welch, The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses (2004), http:\/\/www.ohri.ca\/programs\/clinicalepidemiology\/oxford.htm. Accessed 5 July 2004."},{"key":"1201_CR24","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/s0065-2660(07)00413-0","volume":"60","author":"TA Trikalinos","year":"2008","unstructured":"T.A. Trikalinos, G. Salanti, E. Zintzaras, J.P Ioannidis, Meta-analysis methods. Adv. Genet. 60, 311\u2013334 (2008). doi: 10.1016\/s0065-2660(07)00413-0","journal-title":"Adv. Genet."},{"issue":"7414","key":"1201_CR25","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"J.P. Higgins, S.G. Thompson, J.J. Deeks, D.G. Altman, Measuring inconsistency in meta-analyses. BMJ. 327(7414), 557\u2013560 (2003). doi: 10.1136\/bmj.327.7414.557","journal-title":"BMJ."},{"issue":"11","key":"1201_CR26","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1002\/sim.1752","volume":"23","author":"JP Higgins","year":"2004","unstructured":"J.P. Higgins, S.G. Thompson, Controlling the risk of spurious findings from meta-regression. Stat. Med. 23(11), 1663\u20131682 (2004). doi: 10.1002\/sim.1752","journal-title":"Stat. Med."},{"issue":"1","key":"1201_CR27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/187221410790226756","volume":"4","author":"M Naomi","year":"2010","unstructured":"M. Naomi, F. Saeko, Impact of antihypertensive drug use on bone miner density and osteoporotic fracture-from an epidemiological perspective. Recent Pat Endocr Metab Immune Drug Discov 4(1), 15\u201333 (2010)","journal-title":"Recent Pat Endocr Metab Immune Drug Discov"},{"issue":"2","key":"1201_CR28","first-page":"107","volume":"13","author":"B Medhi","year":"2011","unstructured":"B. Medhi, A. Prakash, S. Kaur, K. Bhagwat, S. Chaudhary, V. Goni, Angiotensin Converting Enzyme Inhibition: Therapeutic Implications in Fracture Healing. JK Science 13(2), 107\u2013108 (2011)","journal-title":"JK Science"},{"issue":"12","key":"1201_CR29","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1002\/acr.21759","volume":"64","author":"JR Curtis","year":"2012","unstructured":"J.R. Curtis, H. Yun, J.L. Lange, R. Matthews, P. Sharma, K.G. Saag, E. Delzell, Does medication adherence itself confer fracture protection? An investigation of the healthy adherer effect in observational data. Arthritis Care Res 64(12), 1855\u20131863 (2012). doi: 10.1002\/acr.21759","journal-title":"Arthritis Care Res"},{"key":"1201_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1745-6215-7-33","volume":"7","author":"CJ Bulpitt","year":"2006","unstructured":"C.J. Bulpitt, R. Peters, J.A. Staessen, L. Thijs, M.C. De Vernejoul, A.E. Fletcher, N.S. Beckett, Fracture risk and the use of a diuretic (indapamide SR) +\/- perindopril: a substudy of the hypertension in the very elderly trial (HYVET). Trials. 7, 33 (2006). doi: 10.1186\/1745-6215-7-33","journal-title":"Trials."},{"issue":"3","key":"1201_CR31","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2165\/00002512-200118030-00001","volume":"18","author":"C Bulpitt","year":"2001","unstructured":"C. Bulpitt, A. Fletcher, N. Beckett, J. Coope, B. Gil-Extremera, F. Forette, C. Nachev, J. Potter, P. Sever, J. Staessen, C. Swift, J. Tuomilehto, Hypertension in the very elderly trial (HYVET): protocol for the main trial. Drugs. Aging. 18(3), 151\u2013164 (2001)","journal-title":"Drugs. Aging."},{"issue":"7","key":"1201_CR32","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1002\/jbmr.356","volume":"26","author":"DH Solomon","year":"2011","unstructured":"D.H. Solomon, H. Mogun, K. Garneau, M.A. Fischer, Risk of fractures in older adults using antihypertensive medications. J. Bone. Miner. Res. 26(7), 1561\u20131567 (2011). doi: 10.1002\/jbmr.356","journal-title":"J. Bone. Miner. Res."},{"issue":"11","key":"1201_CR33","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1002\/jbmr.2271","volume":"29","author":"DA Butt","year":"2014","unstructured":"D.A. Butt, M. Mamdani, T. Gomes, L. Lix, H. Lu, K. Tu, Risk of osteoporotic fractures with angiotensin II receptor blockers versus angiotensin-converting enzyme inhibitors in hypertensive community-dwelling elderly. J. Bone. Miner. Res. 29(11), 2483\u20132488 (2014). doi: 10.1002\/jbmr.2271","journal-title":"J. Bone. Miner. Res."},{"issue":"5","key":"1201_CR34","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1093\/ageing\/afq071","volume":"39","author":"R Peters","year":"2010","unstructured":"R. Peters, N. Beckett, L. Burch, M.C. de Vernejoul, L. Liu, J. Duggan, C. Swift, B. Gil-Extremera, A. Fletcher, C. Bulpitt, The effect of treatment based on a diuretic (indapamide) +\/\u2212 ACE inhibitor (perindopril) on fractures in the hypertension in the very elderly trial (HYVET). Age. Ageing. 39(5), 609\u2013616 (2010). doi: 10.1093\/ageing\/afq071","journal-title":"Age. Ageing."},{"issue":"26","key":"1201_CR35","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1093\/eurheartj\/eht464","volume":"35","author":"R Peters","year":"2014","unstructured":"R. Peters, N. Beckett, T. McCormack, R. Fagard, A. Fletcher, C. Bulpitt, Treating hypertension in the very elderly-benefits, risks, and future directions, a focus on the hypertension in the very elderly trial. Eur. Heart. J. 35(26), 1712\u20131718 (2014). doi: 10.1093\/eurheartj\/eht464","journal-title":"Eur. Heart. J."},{"issue":"18","key":"1201_CR36","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1157\/13095095","volume":"127","author":"A Garcia-Testal","year":"2006","unstructured":"A. Garcia-Testal, A. Monzo, G. Rabanaque, A. Gonzalez, A. Romeu, Evolution of the bone mass of hypertense menopausal women in treatment with fosinopril. Med. Clin. 127(18), 692\u2013694 (2006)","journal-title":"Med. Clin."},{"issue":"6","key":"1201_CR37","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0895-7061(03)00845-8","volume":"16","author":"JL Perez-Castrillon","year":"2003","unstructured":"J.L. Perez-Castrillon, J. Silva, I. Justo, A. Sanz, M. Martin-Luquero, R. Igea, P. Escudero, C. Pueyo, C. Diaz, G. Hernandez, A. Duenas, Effect of quinapril, quinapril-hydrochlorothiazide, and enalapril on the bone mass of hypertensive subjects: relationship with angiotensin converting enzyme polymorphisms. Am. J. Hypertens. 16(6), 453\u2013459 (2003)","journal-title":"Am. J. Hypertens."},{"issue":"1","key":"1201_CR38","first-page":"17","volume":"57","author":"N Masunari","year":"2008","unstructured":"N. Masunari, S. Fujiwara, Y. Nakata, K. Furukawa, F. Kasagi, Effect of angiotensin converting enzyme inhibitor and benzodiazepine intake on bone loss in older Japanese. Hiroshima. J. Med. Sci. 57(1), 17\u201325 (2008)","journal-title":"Hiroshima. J. Med. Sci."},{"issue":"3","key":"1201_CR39","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/ndt\/gft515","volume":"29","author":"R Agarwal","year":"2014","unstructured":"R. Agarwal, A.D. Sinha, M.K. Pappas, T.N. Abraham, G.G. Tegegne, Hypertension in hemodialysis patients treated with atenolol or lisinopril: a randomized controlled trial. Nephrol. Dial. Transplant. 29(3), 672\u2013681 (2014). doi: 10.1093\/ndt\/gft515","journal-title":"Nephrol. Dial. Transplant."},{"issue":"suppl 10","key":"1201_CR40","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1002\/art.26725","volume":"62","author":"M Kinjo","year":"2010","unstructured":"M. Kinjo, S. Setoguchi, D.H. Solomon, Anti-Hypertensive therapy and bone mineral density: analysis in a population-based U.S. sample. Arthritis. Rheum. 62(suppl 10), 956 (2010). doi: 10.1002\/art.26725","journal-title":"Arthritis. Rheum."},{"issue":"2","key":"1201_CR41","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00198-012-2053-3","volume":"24","author":"SD Berry","year":"2013","unstructured":"S.D. Berry, Y. Zhu, H. Choi, D.P. Kiel, Y. Zhang, Diuretic initiation and the acute risk of hip fracture. Osteoporos. Int. 24(2), 689\u2013695 (2013). doi: 10.1007\/s00198-012-2053-3","journal-title":"Osteoporos. Int."},{"issue":"11","key":"1201_CR42","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1001\/jama.292.11.1326","volume":"292","author":"RG Schlienger","year":"2004","unstructured":"R.G. Schlienger, M.E. Kraenzlin, S.S. Jick, C.R. Meier, Use of beta-blockers and risk of fractures. JAMA. 292(11), 1326\u20131332 (2004). doi: 10.1001\/jama.292.11.1326","journal-title":"JAMA."},{"key":"1201_CR43","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ijcard.2015.01.072","volume":"184","author":"HJ Choi","year":"2015","unstructured":"H.J. Choi, C. Park, Y.K. Lee, Y.C. Ha, S. Jang, C.S. Shin, Risk of fractures in subjects with antihypertensive medications: a nationwide claim study. Int. J. Cardiol. 184, 62\u201367 (2015). doi: 10.1016\/j.ijcard.2015.01.072","journal-title":"Int. J. Cardiol."},{"issue":"3","key":"1201_CR44","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s00223-012-9671-9","volume":"92","author":"K Ilic","year":"2013","unstructured":"K. Ilic, N. Obradovic, N. Vujasinovic-Stupar, The relationship among hypertension, antihypertensive medications, and osteoporosis: a narrative review. Calcif. Tissue. Int. 92(3), 217\u2013227 (2013). doi: 10.1007\/s00223-012-9671-9","journal-title":"Calcif. Tissue. Int."},{"issue":"3","key":"1201_CR45","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00774-013-0500-7","volume":"32","author":"TY Diao","year":"2014","unstructured":"T.Y. Diao, H. Pan, S.S. Gu, X. Chen, F.Y. Zhang, M.S. Wong, Y. Zhang, Effects of angiotensin-converting enzyme inhibitor, captopril, on bone of mice with streptozotocin-induced type 1 diabetes. J. Bone. Miner. Metab. 32(3), 261\u2013270 (2014). doi: 10.1007\/s00774-013-0500-7","journal-title":"J. Bone. Miner. Metab."},{"issue":"8","key":"1201_CR46","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.3346\/jkms.2013.28.8.1139","volume":"28","author":"KY Kang","year":"2013","unstructured":"K.Y. Kang, Y. Kang, M. Kim, Y. Kim, H. Yi, J. Kim, H.R. Jung, S.H. Park, H.Y. Kim, J.H. Ju, Y.S. Hong, The effects of antihypertensive drugs on bone mineral density in ovariectomized mice. J. Korean. Med. Sci. 28(8), 1139\u20131144 (2013). doi: 10.3346\/jkms.2013.28.8.1139","journal-title":"J. Korean. Med. Sci."},{"issue":"3","key":"1201_CR47","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1677\/joe.0.1560543","volume":"156","author":"H Hagiwara","year":"1998","unstructured":"H. Hagiwara, Y. Hiruma, A. Inoue, A. Yamaguchi, S. Hirose, Deceleration by angiotensin II of the differentiation and bone formation of rat calvarial osteoblastic cells. J. Endocrinol. 156(3), 543\u2013550 (1998)","journal-title":"J. Endocrinol."},{"issue":"6","key":"1201_CR48","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1093\/ageing\/afh196","volume":"33","author":"L Burton","year":"2004","unstructured":"L. Burton, M. Norton, J.L. Newton, Are some antihypertensives more prone to induce hypotensive side effects than others?. Age. Ageing. 33(6), 626\u2013628 (2004). doi: 10.1093\/ageing\/afh196","journal-title":"Age. Ageing."},{"issue":"7","key":"1201_CR49","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/j.1532-5415.2000.tb04757.x","volume":"48","author":"I Slavachevsky","year":"2000","unstructured":"I. Slavachevsky, R. Rachmani, Z. Levi, D. Brosh, M. Lidar, M. Ravid, Effect of enalapril and nifedipine on orthostatic hypotension in older hypertensive patients. J. Am. Geriatr. Soc. 48(7), 807\u2013810 (2000)","journal-title":"J. Am. Geriatr. Soc."},{"issue":"2","key":"1201_CR50","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2125.1991.tb05522.x","volume":"31","author":"S Capewell","year":"1991","unstructured":"S. Capewell, A. Capewell, \u2018First dose\u2019 hypotension and venodilatation. Br. J. Clin. Pharmacol. 31(2), 213\u2013215 (1991)","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"2","key":"1201_CR51","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/ajh.2010.146","volume":"24","author":"LJ Benvenuto","year":"2011","unstructured":"L.J. Benvenuto, L.R. Krakoff, Morbidity and mortality of orthostatic hypotension: implications for management of cardiovascular disease. Am. J. Hypertens. 24(2), 135\u2013144 (2011). doi: 10.1038\/ajh.2010.146","journal-title":"Am. J. Hypertens."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-016-1201-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-016-1201-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-016-1201-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T02:12:59Z","timestamp":1498356779000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-016-1201-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,19]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["1201"],"URL":"https:\/\/doi.org\/10.1007\/s12020-016-1201-5","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,19]]}}}